Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Platelet Aggregation Devices Market Size Shifted, And What Is the Outlook Through 2034?

The market size for platelet aggregation devices has seen exponential growth in the past years. There will be an increase from $0.83 billion in 2024 to $1.04 billion in 2025, representing a compound annual growth rate (CAGR) of 24.9%. The substantial growth in the historical phase is due to an escalated prevalence of heart diseases, an increase in cases of bleeding disorders, heightened awareness regarding health diagnostics, a surge in surgical procedures, and improved diagnostic accuracy.

The market size for platelet aggregation devices is anticipated to grow exponentially in the coming years, surging to $2.46 billion in 2029 with a compound annual growth rate (CAGR) of 23.9%. Numerous factors can be credited for this growth during the forecast period, such as the ever-growing elderly population, increased requirement for point-of-care testing, the rise of personalized medicine, regulatory support and authorizations, and a growing number of chronic diseases. The forecast period also identifies key trends such as the utilization of artificial intelligence in diagnosis, the creation of portable platelet aggregation gadgets, enhanced collaboration of biotech firms with healthcare providers, the escalating relevance of data analytics in healthcare, and a shift towards home-based diagnostic measures.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15896&type=smp

Which Primay Drivers Are Accelerating Growth in the Platelet Aggregation Devices Market?

The expected rise in specific diseases, referred to as target diseases, is likely to boost the growth of the platelet aggregation devices market. Such target diseases include medical conditions like cancer, cardiovascular diseases, and diabetes that have a significant impact on public health and are prioritised for prevention, treatment, and diagnosis. These devices pave the way for early identification and efficient management of thrombotic risks, thereby preventing complex health issues such as heart attacks and strokes in susceptible individuals. For instance, according to data released by the International Agency for Research on Cancer (IARC), a specialised cancer agency within the World Health Organization (WHO) based in France, around 20 million new cancer cases and 9.7 million deaths were reported in 2022, and the forecast suggests a staggering increase of 77% to above 35 million new cases by 2050. Lung cancer topped the list with 2.5 million new cases (12.4%), trailed by breast cancer in females (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million, 7.3%), and stomach cancer (970,000, 4.9%). Hence, the surge in target diseases is fuelling growth in the platelet aggregation devices market.

Which Primary Segments of the Platelet Aggregation Devices Market Are Driving Growth and Industry Transformations?

The platelet aggregation devicesmarket covered in this report is segmented –

1) By Product: Reagents, Systems, Consumables And Accessories

2) By Type: Four Channel, Dual Channel, Eight Channel

3) By Technology: Optical, Impedance, Other Technologies

4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, Other Applications

5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users

Subsegments:

1) By Reagents: Platelet Aggregation Assay Reagents, Coagulation And Anticoagulation Reagents

2) By Systems: Platelet Aggregation Testing Systems, Automated Platelet Aggregation Systems

3) By Consumables And Accessories: Sample Collection Kits, Testing Plates And Cuvettes, Calibration Kits

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15896&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Platelet Aggregation Devices Market?# Market?

North America was the largest region in the platelet aggregation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Technological Trends Are Reshaping the Platelet Aggregation Devices Industry Dynamics?

Major firms active in the platelet aggregation devices market are shifting their attention to the development of sophisticated solutions, launching groundbreaking products such as the first platelet pooling set to solidify the U.S. platelet supply and cater to escalating demands. A platelet pooling set is a distinct medical tool employed during plateletpheresis operations to amass and enrich platelets from multiple donors into a solitary unit for transfusion therapy. For example, in February 2023, TERUMO BCT INC., an American company specializing in blood components and cellular technology, hailed FDA approval for the IMUGARD WB Platelet Pooling Set. This provided an elongated shelf life for platelets, FDA sanction for seven-day storage, along with the facilitation of platelet recovery from whole blood contributions, boosting flexibility and accessibility in the platelet aggregation devices market. This introduction signifies a crucial technical progression by fulfilling the requirement for enhanced platelet availability, optimizing supply distribution, and backing the pressured U.S. platelet supply in fulfilling the growing need in vital medical processes such as chemotherapy and organ transplants.

View the full report here:

https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report

What Parameters Are Used to Define the Platelet Aggregation Devices Market?

Platelet aggregation devices are specialized instruments used to measure the rate and extent to which platelets clump together, which is crucial for diagnosing and managing disorders related to blood clotting. These devices are used to assess the effectiveness of antiplatelet therapies, diagnose bleeding disorders, and evaluate platelet function in various clinical and research settings.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15896

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model